Navigation Links
Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference
Date:1/15/2014

n patients with diabetes in the outpatient setting. Echo is also developing its needle-free skin preparation component of Symphony, the Prelude® SkinPrep System, as a platform technology to enhance delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts, including the statement about the corporate presentation, may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the safety and efficacy of Echo's Symphony CGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony CGM System, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's and its partners' ability to develop, market and sell the Symphony CGM System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony CGM System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K for the year ended December 31, 2012, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. Echo undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:
Christine H
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- The Green Exchange, Inc., the developer,s of "Loud Cannabis" ... app that connects cannabis growers directly to patients to ... that their service provides the fastest delivery on the ... half a dozen other delivery apps that have popped ... in that it connects growers directly with patients. ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
(Date:7/2/2015)... SHENZHEN, China , 2. Juli 2015 /PRNewswire/ ... Hochdurchsatz-Labor für DNA-Screening in Hongkong vom American ... BGI-Einrichtung in Hongkong ist das erste klinische ... ein CAP-Zertifkat erhält und somit ... Ergänzend zu den bestehenden US FDA - ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, on Feb. ... annual member survey , detailing the most common plastic surgery and minimally invasive ... raw data down into charts detailing demographic trends and regional preferences. With a ...
(Date:7/3/2015)... ... ... Food Bank will hopefully be getting a large donation of canned food items at ... SC are making it their mission to collect as many canned items as possible. Donations ... the public as well. As part of the canned food drive, these local chiropractors will ...
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... ... July 03, 2015 , ... The ... June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. ... bicyclists and practical points of investigating these types of cases. , Each year, ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , ... N. Manzanares, MD as the new Medical Director of its Frisco facility. , “We ... our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... A single compound with dual function the ability to ... be used to enhance the diagnosis, imaging and treatment of ... Virginia Tech. Glioblastomas are the most common and aggressive ... These tumor cells often extend beyond the well-defined tumor margins ...
... Dotinga HealthDay Reporter , WEDNESDAY, Aug. 3 (HealthDay News) ... research suggests that your life choices might not be the crucial ... it finds that many extremely old people appear to have been ... during their younger years. Of course, don,t take this as ...
... Spring Harbor Laboratory (CSHL) and five other institutions have used ... new potential treatment for acute myeloid leukemia (AML). As reported ... have pinpointed a protein called Brd4 as a novel drug ... incurable in 70% of patients. Using a drug compound that ...
... New Rochelle, NY, August 3, 2011Positive activity interventions ... to managing depression and may offer hope to ... or have access to adequate medical therapy, according ... Journal of Alternative and Complementary Medicine , a ...
... 15 years, Kansas State University researcher Michele Borgarelli has ... there is an interesting twist in his work with ... is similar to the same disease affecting humans, making ... Further proof of the bond between owner and dog? ...
... ROCHESTER, Minn. -- Mayo Clinic will receive $10 million ... part of a $220 million grant to its collaborator, ... Republic. The overall award will be used to support ... Center (ICRC) at St. Anne,s and will focus initially ...
Cached Medicine News:Health News:Researchers develop and test new molecule as a delivery vehicle to image and kill brain tumors 2Health News:Genes, Not Healthy Living, Get Most to Age 100 2Health News:Genes, Not Healthy Living, Get Most to Age 100 3Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 2Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 3Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 4Health News:Harnessing the power of positive thoughts and emotions to treat depression 2Health News:A research tale with a heart to match: Professor looks at cardiovascular disease in dogs 2Health News:A research tale with a heart to match: Professor looks at cardiovascular disease in dogs 3Health News:EU $220 million grant supports Mayo-Czech research using 'space station' approach 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: